Five-year data from Genentech SMA study released : vimarsana

SMA patients in the long-term extension Evrysdi study maintained or improved key developmental skills over the five-year period, data shows.

Related Keywords

United Kingdom , Giovanni Baranello , Levi Garraway , Research Clinical Care Meeting , Head Of Global Product Development , Roche Group , Genentech , Institute Of Child Health Hospital , Ormond Street Institute , Child Health , Great Ormond Street Hospital , Chief Medical Officer , Global Product , Clinical Care ,